Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$253,780
-$60,684 QoQ
Shares Held
407
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#985
of 1,321 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alta Advisers Ltd holds $746,039 across 2 Biotechnology names. REGN ranks #2 (34.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
991 | $492,259 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
407 | $253,780 |
All Filings in REGN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $253,780 | 407 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $314,464 | 407 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $314,151 | 407 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $341,297 | 607 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $318,675 | 607 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $384,977 | 607 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $254,301 | 357 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $315,372 | 300 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $315,309 | 300 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $288,747 | 300 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $263,487 | 300 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $246,888 | 300 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $215,562 | 300 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $246,501 | 300 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $216,447 | 300 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $206,661 | 300 | Shares | Sole | 2022-10-28 | |
| No filing history on record for this holder in this stock. | ||||||